<DOC>
	<DOCNO>NCT00003378</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness combination chemotherapy treat patient previously untreated stage III stage IV ovarian primary peritoneal cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Previously Untreated Stage III Stage IV Ovarian Primary Peritoneal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine feasibility administer multiple course chemotherapy without excessive dose modification treatment delay patient previously untreated ovarian epithelial carcinoma primary peritoneal carcinoma . II . Determine response rate ( patient measurable disease ) progression-free interval patient receive treatment . OUTLINE : This feasibility study . On day 1 , patient receive paclitaxel 3 hour continuous IV infusion follow carboplatin 30 minute infusion . Gemcitabine administer continuous infusion 30 minute day 1 follow carboplatin day 8 . In absence disease progression unacceptable toxicity , course repeat every 21 day maximum 8 course . Patients follow every 3 month 2 year , every 6 month next 3 year , annually thereafter . PROJECTED ACCRUAL : A total 15-45 patient accrue study within approximately 2 year .</detailed_description>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm , previously untreated : Stage III stage IV ovarian epithelial cancer Stage III stage IV primary peritoneal cancer PATIENT CHARACTERISTICS : Age : 18 80 Performance status : GOG 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT great 3 time ULN Alkaline phosphatase great 3 time ULN Renal : Creatinine great 1.5 mg/dL Other : Effective contraception require fertile patient No significant infection No severe medical problem would subject patient undue risk protocol No active malignancy within past 5 year except nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy malignancy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy malignancy Surgery : No prior surgery cytoreductive surgery recover</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>primary peritoneal cavity cancer</keyword>
</DOC>